Star Combo Pharma Ltd Cash Flow-to-Debt Ratio
Star Combo Pharma Ltd cash flow-to-debt ratio. Star Combo Pharma Ltd (S66) has a Cash Flow-to-Debt Ratio of 0.07x as of December 2025, meaning its operating cash flow of AU$575.23K could theoretically repay 0% of its total liabilities (AU$8.30 Million) in one year. Check cash flow reinvestment rate of Star Combo Pharma Ltd to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Star Combo Pharma Ltd (2016–2025)
Cash flow-to-debt ratio of Star Combo Pharma Ltd from 2016 to 2025. Historical debt coverage capacity for Star Combo Pharma Ltd across 10 annual periods. Check S66 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Star Combo Pharma Ltd Cash Flow-to-Debt Ratio by Year (2016–2025)
Star Combo Pharma Ltd cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Star Combo Pharma Ltd. For the full cash flow conversion analysis, see how efficiently does Star Combo Pharma Ltd generate cash.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.17x | AU$11.94 Million | AU$10.19 Million | ▲ +3546.3% |
| 2024 | -0.03x | AU$-316.45K | AU$9.30 Million | ▼ -116.3% |
| 2023 | 0.21x | AU$1.88 Million | AU$8.97 Million | ▲ +1831.2% |
| 2022 | 0.01x | AU$87.11K | AU$8.04 Million | ▼ -76.7% |
| 2021 | 0.05x | AU$331.53K | AU$7.13 Million | ▲ +146.7% |
| 2020 | -0.10x | AU$-1.02 Million | AU$10.22 Million | ▲ +65.8% |
| 2019 | -0.29x | AU$-2.19 Million | AU$7.51 Million | ▲ +56.0% |
| 2018 | -0.66x | AU$-1.84 Million | AU$2.78 Million | ▼ -358.1% |
| 2017 | 0.26x | AU$932.20K | AU$3.64 Million | ▼ -36.6% |
| 2016 | 0.40x | AU$1.30 Million | AU$3.21 Million | — |